Louisville's adult obesity rate, Kentucky Medicaid's pending GLP-1 proposal, the published local cash prices, and the west- and south-end primary care shortage, each figure sourced.
36.3% of adults in Louisville/Jefferson County metro government (balance) have obesity, per the CDC's PLACES place-level estimates drawn from the 2022 BRFSS 1. That is the latest place-level figure available for the city: Kentucky sat out the 2023 BRFSS, so the 2025 PLACES release carries no Kentucky obesity estimate at all 3. These figures are for FIPS 2148006, not the separate "Louisville" FIPS 2148000 geography, which reads 39.5% 1.
Year-matched, Jefferson County sits at 37.0% (BRFSS 2022) 2, and Kentucky adults were at 37.2% in the 2024 BRFSS, down from 37.7% in 2022 4. Louisville sits essentially at the level of one of the country's most obesity-burdened states. What decides whether a Louisville household can treat that is who pays, and in Kentucky that answer is still pending.
As of Feb 23, 2026, Kentucky Medicaid covers GLP-1s only for FDA-approved indications, primarily diabetes: roughly 20,000 Kentucky Medicaid members use them, nearly all for diabetes, and obesity alone is not a covered indication 13.
That same day, Department for Medicaid Services Commissioner Lisa Lee told the Medicaid Oversight and Advisory Board that the state is considering expanding access for members with obesity-related underlying conditions, under the December 2025 voluntary federal program that lets state Medicaid agencies cover GLP-1s for weight management at negotiated prices, with roughly $245 a month cited against about $900 retail 13. Thirteen state Medicaid programs covered GLP-1s for obesity as of January 2026, and Kentucky was not among them 13. Re-checked in August 2026, it remains a proposal: nothing has been enacted, so a Louisville member should plan around today's rules, not the announcement.
The defining fact of this market is silence. Of seven Louisville GLP-1 providers checked on Aug 27, 2026, five publish no dollar price on their own websites: Glow by K2, whose weight-loss page claims "transparent pricing" and lists none, Louisville Laser Med Spa, Gameday Men's Health Louisville, RevitaLife MD, and Louisville Center for Weight Loss, whose site is a client-rendered app with no server-visible pricing 1112. The "$175/8 doses" figure circulating for that last clinic appears only on third-party directories, never on its own site, and is reported here as unverified.
The two that do publish are priced well above the national telehealth tier. Renew Health & Wellness in Middletown charges "$250 per month, plus the cost of medication" on a three-month initial commitment, with compounded tirzepatide listed as starting at $250 a month and Mounjaro at $1,800 a month, so roughly $500 a month all-in at the starting tier and priced upward from there 9. Ageless Center on Forest Green Boulevard advertises a limited-time "$99/Week Medical Weight Loss + 4 FREE B12 Shots," about $429 a month, on a page that never states whether GLP-1 medication is included at that rate and does not publish a standard program price 10.
Astra's price is national and stated once: compounded semaglutide from $68 per month and compounded tirzepatide from $118 per month on 12-month plans, $816 and $1,416 billed annually. It is the same in Louisville as in every other city, and the same at every dose. There is no Louisville rate, discount, or promotion.
Louisville is unusually strong for a tier-2 metro because it has academic obesity medicine inside the city. UofL Health runs Advanced Bariatrics and Medical Weight Management at the Chestnut Street Outpatient Center downtown, tied to the University of Louisville School of Medicine 14, and Norton Healthcare operates Norton Weight Management Services at 1000 DuPont Rd, with MBSAQIP-accredited metabolic and bariatric surgery at Norton Women's & Children's Hospital 15.
The real gap is geography inside the city. HRSA currently designates three low-income primary care shortage areas in Jefferson County, all designated mid-2025: LI-Jefferson County 6 Northwest (score 20, designation population 66,474), LI-Jefferson County 5 South Central (score 19, population 51,987), and LI-Jefferson County 7 Southwest (score 18, population 38,346), roughly 157,000 low-income residents of west, southwest, and south-central Louisville 8. Three FQHC-based designations are also active, each scoring 22: Family Health Centers, Park DuValle Community Health Center, and Shawnee Christian Healthcare Center 8. Older geographic designations for the West End, Shawnee-Chickasaw, and Beuchel/Newburg have been withdrawn 8.
So what telehealth answers in Louisville is cost and referral friction at hospital programs, plus primary-care scarcity in the west and south ends, not distance to a specialist. Statewide prescribing and pharmacy rules live on the Kentucky GLP-1 hub.
Astra treats patients in Kentucky through state-licensed physicians.
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. A licensed physician decides whether treatment is appropriate for you.
Monthly self-pay prices published by local providers, compared with Astra's online programs and the manufacturers' own self-pay prices for brand-name drugs. Compounded and brand-name medications are different products; compounded medications are not FDA-approved.
| Provider | Per month | Basis | Source |
|---|---|---|---|
| Renew Health & Wellness — tirzepatide | $250 | per month medication, "Starts at only"; plus separate $250/month program fee | source, checked 2026-08-27 |
| Astra — compounded semaglutide | $68 | per month, 12-month plan | program page |
| Astra — compounded tirzepatide | $118 | per month, 12-month plan | program page |
| Wegovy pen — NovoCare self-pay | $349 | per month, standard price | price index |
| Zepbound® — LillyDirect self-pay | $299–$449 | per month, by dose | price index |
Yes — online, for patients in Kentucky. Astra has two current promo codes:
Code
Compounded tirzepatide: code NEWSTART — $100 off. $109/mo instead of $118/mo on the 12-month plan ($1,316 billed once instead of $1,416).
Apply NEWSTART automatically →Code
Compounded semaglutide: code Sema NewStart — $30 off. Applied at checkout; plans start at $68/mo on the 12-month plan ($816 billed once) before the discount.
Apply Sema NewStart automatically →Click a button to start with the code already applied, or type the code during checkout. NEWSTART applies to the 12-month compounded tirzepatide plan. Plans are billed upfront, renew automatically and can be cancelled any time. A licensed physician decides whether treatment is appropriate; a visit does not guarantee a prescription. Compounded medications are not FDA-approved. Subscription terms · Refund policy. Last verified 2026-10-01.
All Astra promo codes · Semaglutide coupon guide · Tirzepatide coupon guide
Mostly, Louisville clinics won't tell you: five of the seven providers checked on Aug 27, 2026 (Glow by K2, Louisville Laser Med Spa, Gameday Men's Health, RevitaLife MD, Louisville Center for Weight Loss) publish no dollar price on their own websites. Of the two that do, Renew Health & Wellness charges $250/month for its program plus medication — compounded tirzepatide starts at $250/month (roughly $500/month all-in at the floor) and Mounjaro is listed at $1,800/month — and Ageless Center advertises a limited-time $99/week special (about $429/month) that doesn't state whether GLP-1 medication is included. Astra's national price is $68/month for semaglutide and $118/month for tirzepatide on 12-month plans.
Not for weight loss alone. As of Feb 23, 2026, Kentucky Medicaid covers GLP-1s only for FDA-approved indications — primarily diabetes; roughly 20,000 Kentucky Medicaid members take them, nearly all for diabetes. Medicaid Commissioner Lisa Lee told the Medicaid Oversight and Advisory Board that day that Kentucky is considering expanding access for members with obesity-related underlying conditions under a December 2025 voluntary federal program (negotiated prices around $245/month were cited versus roughly $900 retail), but as of January 2026 Kentucky was not among the 13 state Medicaid programs covering GLP-1s for obesity — and as of August 2026 the expansion is still a proposal, not an enacted change.
Against every published Louisville price we could verify, yes: Renew Health & Wellness's compounded tirzepatide works out to roughly $500/month all-in at its starting tier versus Astra's $118/month, and Ageless Center's limited-time $99/week special is about $429/month — without its page stating that GLP-1 medication is included at that rate. But Astra is not running a Louisville discount: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans is the national price, the same in every city and at every dose.
Yes — Louisville is unusually well-supplied with hospital-system obesity medicine for a metro its size. UofL Health runs Advanced Bariatrics and Medical Weight Management at the Chestnut Street Outpatient Center downtown, tied to the University of Louisville School of Medicine, and Norton Healthcare operates Norton Weight Management Services on DuPont Road, with MBSAQIP-accredited metabolic and bariatric surgery at Norton Women's & Children's Hospital. The practical barriers at these programs are cost, referral steps, and appointment lead times rather than distance.
That is where the gap is concentrated. HRSA currently designates three low-income primary care shortage areas covering roughly 157,000 residents of northwest, southwest, and south-central Louisville (HPSA scores 18–20, all designated mid-2025), plus three active FQHC-based designations — Family Health Centers, Park DuValle Community Health Center, and Shawnee Christian Healthcare Center, each scoring 22. Telehealth exists for exactly this situation: a clinician visit from home instead of hunting for a primary-care appointment inside a shortage area. Check current availability in Kentucky on this page.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.